Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Quantum Biopharma Ltd. (V.QNT) had Income from Continuous Operations of -20.44M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-20.44M |
|
-- |
|
-- |
|
-- |
|
-22.12M |
|
-- |
|
-20.44M |
|
-20.44M |
|
-20.44M |
|
|
Income from Continuous Operations |
-20.44M |
-20.44M |
|
-20.44M |
|
-22.12M |
|
-21.44M |
|
1.14M |
|
1.14M |
|
-17.98 |
|
-17.98 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
23.46M |
|
-- |
|
-- |
|
-- |
|
9.15M |
|
14.31M |
|
7.55M |
|
14.31M |
|
2.30M |
|
| Cash Flow Statement Financials | |
-9.42M |
|
-2.06M |
|
15.92M |
|
3.78M |
|
8.22M |
|
4.44M |
|
0.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.80 |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-142.87% |
|
-270.88% |
|
-87.13% |
|
-142.87% |
|
6.22 |
|
-8.29 |
|
-8.29 |
|